跳至主要内容
临床试验/NCT03208972
NCT03208972已完成4 期

Prospective Randomized Trial Comparing Ovarian Stimulation in IVF-patients With Corifollitropin Alfa in Combination With Hp-FSH Versus Corifollitropin Alfa in Combination With Low Dose hCG

AZ Jan Palfijn Gent1 个研究点 分布在 1 个国家目标入组 107 人开始时间: 2014年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
107
试验地点
1
主要终点
The financial costs of the stimulation in both groups

研究概览

简要总结

The study compares in a randomized controlled way two stimulation methods. One of these stimulation methods implements a new insight in ovarian follicular growth. If this novel method of stimulation proves to be as efficient as the classical stimulation protocols, there might be a dramatic reduction of the costs of the medical therapy in IVF, thus reducing also the overall IVf costs significantly.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 38 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • IVF/ICSI patients
  • Cycle 1, 2, 3, 4

排除标准

  • Endocrinological diseases

研究组 & 干预措施

low dose hCG (Pregnyl)

Experimental

Corifollitropin Alfa (Elonva) dosage depending on weight once administered first day of ovarian stimulation in combination 150IU low dose hCG from day 7 until final oocyte maturation.

干预措施: low dose hCG (Drug)

low dose hCG (Pregnyl)

Experimental

Corifollitropin Alfa (Elonva) dosage depending on weight once administered first day of ovarian stimulation in combination 150IU low dose hCG from day 7 until final oocyte maturation.

干预措施: Corifollitropin Alfa (Drug)

hp-FSH (Menopur)

Active Comparator

Corifollitropin Alfa (Elonva) dosage depending on weight once administered first day of ovarian stimulation in combination with hp-FSH until final oocyte maturation.

干预措施: hp-FSH (Drug)

hp-FSH (Menopur)

Active Comparator

Corifollitropin Alfa (Elonva) dosage depending on weight once administered first day of ovarian stimulation in combination with hp-FSH until final oocyte maturation.

干预措施: Corifollitropin Alfa (Drug)

结局指标

主要结局

The financial costs of the stimulation in both groups

时间窗: 1 year

次要结局

  • pregnancy rate(5 weeks)
  • duration of the stimulation(one month)
  • The number of MII oocytes obtained at the occasion of the oocyte retrieval(3 weeks)
  • hormonal levels reached at time of induction of final maturation of the oocyte(3 weeks)
  • the number of clinical OHSS patients(one month)

研究者

发起方
AZ Jan Palfijn Gent
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Decleer Wim

Principal Investigator

AZ Jan Palfijn Gent

研究点 (1)

Loading locations...

相似试验

Elonva in Combination With Hp-FSH Versus Elonva With... | 临床试验